Works from 2023
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing, Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al. (Article)
Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study, Lorenzo Gerratana, Yue Ren, Rubina Qamar, et al. (Abstract)
Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system, Noor Naffakh, Michael Williams, Priyam Patel, et al. (Abstract)
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI), Anna Couvillon, Baris Turkbey, Michael P. Mullane, et al. (Abstract)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Works from 2022
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system, Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al. (Abstract)
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: Updated results of the E1912 trial, Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, et al. (Article)
Management of metastatic clear cell renal cell carcinoma: ASCO guideline, W Kimryn Rathmell, R Bryan Rumble, Peter J. Van Veldhuizen, et al. (Article)
Quantifying the value of the molecular tumor board: Discordance recommendation rate and drug cost avoidance, Mary K. Walters, Andrew T. Ackerman, James L. Weese, et al. (Article)
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies, Michael A. Thompson, Sigrun Hallmeyer, Veronica E. Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, and James L. Weese (Original Research)
Recurrent venous thromboembolism in a patient with nephrotic syndrome on rivaroxaban therapy, Dorota Magdon and Magdalena Flejsierowicz (Poster)
Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL, Zaid Al-Kadhimi, Samuel Pirruccello, Zartash Gul, et al. (Letter)
Vitamin B12 deficiency as unexpected cause of hemolytic anemia and atypical presentation of hepatocellular adenoma, Andrew Gregory and Magdalena Flejsierowicz (Poster)